Annual Non Current Assets
$33.93 M
-$1.11 M-3.16%
31 December 2023
Summary:
Celldex Therapeutics annual long term assets is currently $33.93 million, with the most recent change of -$1.11 million (-3.16%) on 31 December 2023. During the last 3 years, it has fallen by -$4.06 million (-10.69%). CLDX annual non current assets is now -81.93% below its all-time high of $187.79 million, reached on 31 December 2016.CLDX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$44.34 M
+$10.73 M+31.91%
01 September 2024
Summary:
Celldex Therapeutics quarterly long term assets is currently $44.34 million, with the most recent change of +$10.73 million (+31.91%) on 01 September 2024. Over the past year, it has increased by +$10.01 million (+29.18%). CLDX quarterly non current assets is now -76.39% below its all-time high of $187.79 million, reached on 31 December 2016.CLDX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLDX Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.2% | +29.2% |
| 3 y3 years | -10.7% | +31.8% |
| 5 y5 years | -40.2% | -21.9% |
CLDX Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -10.7% | +0.3% | at high | +33.0% |
| 5 y | 5 years | -40.2% | +0.3% | -21.9% | +33.0% |
| alltime | all time | -81.9% | +8383.5% | -76.4% | >+9999.0% |
Celldex Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $44.34 M(+31.9%) |
| June 2024 | - | $33.61 M(+0.3%) |
| Mar 2024 | - | $33.52 M(-1.2%) |
| Dec 2023 | $431.69 M(+35.9%) | $33.93 M(-1.1%) |
| Sept 2023 | - | $34.32 M(-0.5%) |
| June 2023 | - | $34.49 M(-1.2%) |
| Mar 2023 | - | $34.92 M(-0.3%) |
| Dec 2022 | $317.69 M(-22.7%) | $35.04 M(+1.2%) |
| Sept 2022 | - | $34.63 M(-1.0%) |
| June 2022 | - | $34.98 M(+4.9%) |
| Mar 2022 | - | $33.34 M(-1.4%) |
| Dec 2021 | $410.84 M(+107.7%) | $33.81 M(+0.5%) |
| Sept 2021 | - | $33.65 M(-8.9%) |
| June 2021 | - | $36.95 M(-1.7%) |
| Mar 2021 | - | $37.57 M(-1.1%) |
| Dec 2020 | $197.84 M(+196.6%) | $37.99 M(-28.1%) |
| Sept 2020 | - | $52.84 M(+0.8%) |
| June 2020 | - | $52.41 M(-7.4%) |
| Mar 2020 | - | $56.59 M(+0.6%) |
| Dec 2019 | $66.70 M(-32.7%) | $56.23 M(-0.9%) |
| Sept 2019 | - | $56.74 M(-2.0%) |
| June 2019 | - | $57.88 M(-1.4%) |
| Mar 2019 | - | $58.73 M(+3.5%) |
| Dec 2018 | $99.08 M(-31.6%) | $56.73 M(-1.0%) |
| Sept 2018 | - | $57.32 M(-1.3%) |
| June 2018 | - | $58.10 M(-3.8%) |
| Mar 2018 | - | $60.40 M(-64.6%) |
| Dec 2017 | $144.76 M(-26.0%) | $170.87 M(-0.7%) |
| Sept 2017 | - | $172.10 M(-7.5%) |
| June 2017 | - | $186.02 M(-0.3%) |
| Mar 2017 | - | $186.59 M(-0.6%) |
| Dec 2016 | $195.57 M(-33.7%) | $187.79 M(+344.6%) |
| Sept 2016 | - | $42.23 M(-0.5%) |
| June 2016 | - | $42.42 M(+3.5%) |
| Mar 2016 | - | $40.98 M(-3.9%) |
| Dec 2015 | $294.94 M(+43.9%) | $42.65 M(-1.7%) |
| Sept 2015 | - | $43.38 M(-0.7%) |
| June 2015 | - | $43.68 M(+0.2%) |
| Mar 2015 | - | $43.57 M(+1.3%) |
| Dec 2014 | $204.99 M(-32.8%) | $43.03 M(+2.8%) |
| Sept 2014 | - | $41.84 M(-0.4%) |
| June 2014 | - | $41.99 M(+0.3%) |
| Mar 2014 | - | $41.88 M(-0.1%) |
| Dec 2013 | $305.19 M(+258.6%) | $41.91 M(+2.2%) |
| Sept 2013 | - | $41.01 M(+3.0%) |
| June 2013 | - | $39.80 M(-0.3%) |
| Mar 2013 | - | $39.91 M(-1.3%) |
| Dec 2012 | $85.11 M(+55.6%) | $40.43 M(-1.5%) |
| Sept 2012 | - | $41.03 M(-1.7%) |
| June 2012 | - | $41.73 M(-1.8%) |
| Mar 2012 | - | $42.50 M(-1.9%) |
| Dec 2011 | $54.68 M(-13.1%) | $43.31 M(-1.7%) |
| Sept 2011 | - | $44.07 M(-2.5%) |
| June 2011 | - | $45.19 M(-2.1%) |
| Mar 2011 | - | $46.18 M(-1.7%) |
| Dec 2010 | $62.95 M(-25.0%) | $47.00 M(-10.7%) |
| Sept 2010 | - | $52.61 M(-1.3%) |
| June 2010 | - | $53.32 M(-1.6%) |
| Mar 2010 | - | $54.16 M(-3.9%) |
| Dec 2009 | $83.98 M(+78.4%) | $56.39 M(+180.6%) |
| Sept 2009 | - | $20.09 M(-3.9%) |
| June 2009 | - | $20.90 M(-3.4%) |
| Mar 2009 | - | $21.64 M(-4.7%) |
| Dec 2008 | $47.08 M(+726.1%) | $22.72 M(-3.8%) |
| Sept 2008 | - | $23.62 M(+36.4%) |
| June 2008 | - | $17.32 M(-4.5%) |
| Mar 2008 | - | $18.13 M(+393.1%) |
| Dec 2007 | $5.70 M(-86.6%) | $3.68 M(-83.3%) |
| Sept 2007 | - | $22.02 M(+0.7%) |
| June 2007 | - | $21.88 M(+7.2%) |
| Mar 2007 | - | $20.42 M(+7.0%) |
| Dec 2006 | $42.40 M | $19.08 M(+20.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2006 | - | $15.89 M(+17.2%) |
| June 2006 | - | $13.56 M(+12.4%) |
| Mar 2006 | - | $12.06 M(+1.8%) |
| Dec 2005 | $24.60 M(-28.8%) | $11.85 M(+3.3%) |
| Sept 2005 | - | $11.47 M(+0.7%) |
| June 2005 | - | $11.39 M(+1.0%) |
| Mar 2005 | - | $11.28 M(+0.1%) |
| Dec 2004 | $34.54 M(+54.8%) | $11.26 M(+18.3%) |
| Sept 2004 | - | $9.52 M(+9.4%) |
| June 2004 | - | $8.70 M(-2.1%) |
| Mar 2004 | - | $8.89 M(-1.2%) |
| Dec 2003 | $22.31 M(-13.7%) | $9.00 M(-13.4%) |
| Sept 2003 | - | $10.39 M(-3.3%) |
| June 2003 | - | $10.75 M(-3.2%) |
| Mar 2003 | - | $11.10 M(+18.4%) |
| Dec 2002 | $25.86 M(-40.3%) | $9.37 M(-1.8%) |
| Sept 2002 | - | $9.55 M(-2.5%) |
| June 2002 | - | $9.79 M(-1.8%) |
| Mar 2002 | - | $9.96 M(-1.8%) |
| Dec 2001 | $43.34 M(-16.3%) | $10.14 M(-4.9%) |
| Sept 2001 | - | $10.67 M(-2.4%) |
| June 2001 | - | $10.93 M(-3.1%) |
| Mar 2001 | - | $11.28 M(-4.1%) |
| Dec 2000 | $51.81 M(+257.5%) | $11.76 M(+174.2%) |
| Sept 2000 | - | $4.29 M(-6.2%) |
| June 2000 | - | $4.57 M(-6.0%) |
| Mar 2000 | - | $4.86 M(-9.8%) |
| Dec 1999 | $14.49 M(-7.1%) | $5.39 M(-7.0%) |
| Sept 1999 | - | $5.80 M(-9.4%) |
| June 1999 | - | $6.40 M(-7.2%) |
| Mar 1999 | - | $6.90 M(-2.1%) |
| Dec 1998 | $15.60 M(+110.8%) | $7.05 M(-19.9%) |
| Sept 1998 | - | $8.80 M(+183.9%) |
| June 1998 | - | $3.10 M(+24.0%) |
| Mar 1998 | - | $2.50 M(+4.2%) |
| Dec 1997 | $7.40 M(-44.4%) | $2.40 M(-4.0%) |
| Sept 1997 | - | $2.50 M(+4.2%) |
| June 1997 | - | $2.40 M(0.0%) |
| Mar 1997 | - | $2.40 M(-38.5%) |
| Dec 1996 | $13.30 M(-2.2%) | $3.90 M(-7.1%) |
| Sept 1996 | - | $4.20 M(-2.3%) |
| June 1996 | - | $4.30 M(-28.3%) |
| Mar 1996 | - | $6.00 M(+22.4%) |
| Dec 1995 | $13.60 M(-23.2%) | $4.90 M(+22.5%) |
| Sept 1995 | - | $4.00 M(+37.9%) |
| June 1995 | - | $2.90 M(0.0%) |
| Mar 1995 | - | $2.90 M(-3.3%) |
| Dec 1994 | $17.70 M(-40.0%) | $3.00 M(-25.0%) |
| Sept 1994 | - | $4.00 M(0.0%) |
| June 1994 | - | $4.00 M(+14.3%) |
| Mar 1994 | - | $3.50 M(-2.8%) |
| Dec 1993 | $29.50 M(+53.6%) | $3.60 M(0.0%) |
| Sept 1993 | - | $3.60 M(+2.9%) |
| June 1993 | - | $3.50 M(+6.1%) |
| Mar 1993 | - | $3.30 M(+6.5%) |
| Dec 1992 | $19.20 M(-20.7%) | - |
| Oct 1992 | - | $3.10 M(+6.9%) |
| July 1992 | - | $2.90 M(+3.6%) |
| Apr 1992 | - | $2.80 M(+3.7%) |
| Apr 1992 | $24.20 M(+128.3%) | - |
| Jan 1992 | - | $2.70 M(+3.8%) |
| Oct 1991 | - | $2.60 M(-3.7%) |
| July 1991 | - | $2.70 M(+3.8%) |
| Apr 1991 | $10.60 M(-16.5%) | $2.60 M(-3.7%) |
| Jan 1991 | - | $2.70 M(0.0%) |
| Oct 1990 | - | $2.70 M(-3.6%) |
| July 1990 | - | $2.80 M(-3.4%) |
| Apr 1990 | $12.70 M(+18.7%) | $2.90 M(+11.5%) |
| Jan 1990 | - | $2.60 M(+4.0%) |
| Apr 1989 | $10.70 M(-7.8%) | $2.50 M(+78.6%) |
| Apr 1988 | $11.60 M(-17.1%) | $1.40 M(+133.3%) |
| Apr 1987 | $14.00 M(+400.0%) | $600.00 K(+50.0%) |
| Apr 1986 | $2.80 M | $400.00 K |
FAQ
- What is Celldex Therapeutics annual long term assets?
- What is the all time high annual non current assets for Celldex Therapeutics?
- What is Celldex Therapeutics annual non current assets year-on-year change?
- What is Celldex Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly non current assets year-on-year change?
What is Celldex Therapeutics annual long term assets?
The current annual non current assets of CLDX is $33.93 M
What is the all time high annual non current assets for Celldex Therapeutics?
Celldex Therapeutics all-time high annual long term assets is $187.79 M
What is Celldex Therapeutics annual non current assets year-on-year change?
Over the past year, CLDX annual long term assets has changed by -$1.11 M (-3.16%)
What is Celldex Therapeutics quarterly long term assets?
The current quarterly non current assets of CLDX is $44.34 M
What is the all time high quarterly non current assets for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly long term assets is $187.79 M
What is Celldex Therapeutics quarterly non current assets year-on-year change?
Over the past year, CLDX quarterly long term assets has changed by +$10.01 M (+29.18%)